Najlepsze podcasty z kategorii: NEJM (2024)

1
NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities. 7:13

2d ago7:13

7:13

Vincent Guilamo-Ramos is the executive director of the Institute for Policy Solutions at the Johns Hopkins School of Nursing. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. V. Guilamo-Ramos, M. Thimm-Kaiser, and A. Benzekri. The U.S. Latino HIV Crisis — Ending an Era of Invisibility. N Engl J Med 2024;391:1665-…

1
NEJM This Week — November 7, 2024 27:04

2d ago27:04

27:04

Featuring articles on an invasive treatment strategy in older patients with myocardial infarction, a randomized trial of very early medication abortion, therapies in stage III melanoma, and on long Covid defined; a review article on uterine fibroids; a Clinical Problem-Solving on two sides to the story; and Perspectives on the U.S. Latino HIV crisi…

1
The Pulse of Progress: AI in Cardiology with Dr. David Ouyang 50:23

23d ago50:23

50:23

In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. David Ouyang, a cardiologist and AI researcher at Cedars-Sinai Medical Center. The conversation explores Ouyang’s journey from medical training to AI research and entrepreneurship, his groundbreaking work in applying AI to cardiology imaging, and the challenges of…

1
The Marburg Virus Outbreak in Rwanda 33:27

2d ago33:27

33:27

In this audio interview conducted on October 30, 2024, the editors are joined by the Minister of Health of Rwanda to discuss both actions taken to halt the spread of disease and the use of experimental vaccines and therapies. Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Sabin Nsanzimana, M.D., P…

1
NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks. 13:41

9d ago13:41

13:41

Liam McCoy is a resident physician in neurology at the University of Alberta. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.G. McCoy, A.K. Manrai, and A. Rodman. Large Language Models and the Degradation of the Medical Record. N Engl J Med 2024;391:1561-1564.

1
NEJM This Week — October 31, 2024 33:00

9d ago33:00

33:00

Featuring articles on semaglutide in persons with obesity and knee osteoarthritis, the addition of PI3K inhibition in breast cancer, treatments in older patients with myeloma, and total hip replacement for hip osteoarthritis; a review article on lead poisoning; a case report of a man with dyspnea after old myocardial infarction; and Perspectives on…

1
NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health. 8:02

16d ago8:02

8:02

Mark Wicclair is an adjunct professor of medicine at the University of Pittsburgh Center for Bioethics and Health Law and a professor of philosophy emeritus at West Virginia University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.B. White and M. Wicclair. Navigating Clinicians’ Conscience-Based Refusals to…

1
NEJM This Week — October 24, 2024 31:38

16d ago31:38

31:38

Featuring articles on treatments in heart failure, advanced non–small-cell lung cancer, and Dupuytren’s contracture; a neurodevelopmental disorder caused by deletion in a long noncoding RNA; a review article on burnout and depression among physicians; a case report of a woman with confusion, aphasia, and a brain mass; a Medicine and Society article…

1
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity. 21:26

23d ago21:26

21:26

Jose Figueroa is an associate professor of health policy and management at the Harvard T.H. Chan School of Public Health and an assistant professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. McWilliams and S.B. Dusetzina. Affordability of Health Care in the United…

1
NEJM This Week — October 17, 2024 29:33

23d ago29:33

29:33

Featuring articles on nivolumab in advanced Hodgkin’s lymphoma, kidney transplantation from donors with HIV, a modular communicative leadless pacing–defibrillator system, stereotactic body radiotherapy in prostate cancer, and on how DNA sensing drives inflammation; a review article on cryoglobulinemia; a case report of a woman with dyspnea, dysphag…

1
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern. 9:20

1M ago9:20

9:20

Jean Nachega is an associate professor of infectious diseases and microbiology and of epidemiology at the University of Pittsburgh School of Public Health and a professor of medicine at Stellenbosch University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.B. Nachega and Others. Mpox in Pregnancy — Risks, Ve…

1
NEJM This Week — October 10, 2024 31:10

1M ago31:10

31:10

Featuring articles on beta-blocker use after myocardial infarction and treatments for cerebral adrenoleukodystrophy and for small-cell lung cancer; a review article on hairy-cell leukemia; a case report of a man with fever, myalgia, jaundice, and respiratory failure; and Perspectives on Mpox, on addressing health care cost growth, and on confirmato…

1
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform. 8:47

1M ago8:47

8:47

Jonathan Oberlander is a professor of social medicine and of health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Oberlander. Health Care Reform and the 2024 U.S. Elections — Low Visibility, High Stakes. N Engl J Med 2024;391:1169-117…

1
NEJM This Week — October 3, 2024 34:28

1M ago34:28

34:28

Featuring articles on lenacapavir for HIV prevention in cisgender women, tirzepatide for treatment of obstructive sleep apnea, lymphadenectomy for muscle-invasive bladder cancer, secondary T-cell lymphoma after CAR T-cell therapy, and immunity and early colorectal carcinogenesis; a review article on prolonged grief disorder; a Clinical Problem-Solv…

1
NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions. 10:12

1M ago10:12

10:12

Abigail Cutler is an assistant professor and associate residency program director in the Department of Obstetrics and Gynecology at the University of Wisconsin School of Medicine and Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Cutler and E. Hartenbach. Dobbs Revisited — Addressing Effects…

1
NEJM This Week — September 26, 2024 33:29

1M ago33:29

33:29

Featuring articles on systematic vs. targeted biopsy for prostate cancer screening, ziresovir in hospitalized infants with RSV, gene therapy for factor IX deficiency, and a phase 2 trial of tulisokibart for ulcerative colitis; a review article on neuroleptic malignant syndrome; a case report of a woman with kidney lesions and lytic bone disease; an…

1
NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs. 11:56

2M ago11:56

11:56

Charles Weijer is a professor in the Departments of Medicine and Philosophy at Western University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C. Weijer and M. Taljaard. Ethical Challenges Associated with Pragmatic and Cluster RCTs. N Engl J Med 2024;391:969-971.…

1
NEJM This Week — September 19, 2024 32:37

2M ago32:37

32:37

Featuring articles on long-term oxygen therapy in severe hypoxemia, reducing opioid overdose deaths, blocking CSF1R in chronic GVHD, and pomalidomide in hereditary hemorrhagic telangiectasia; a review article on central nervous system vasculitis; a case report of a man with confusion and kidney failure; a Medicine and Society on house staff unioniz…

1
AI at the Frontlines: Dissecting Clalit’s Roadmap for the Future of Public Health with Noa Dagan and Ran Balicer 1:11:23

2M ago1:11:23

1:11:23

In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. Noa Dagan and Dr. Ran Balicer from the Clalit Research Institute in Israel. The conversation explores Clalit’s groundbreaking work in implementing predictive models at the point of care, their contributions to COVID-19 research, and the potential of AI in revoluti…

1
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma 2:58

2M ago2:58

2:58

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors 2:56

2M ago2:56

2:56

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer 3:25

2M ago3:25

3:25

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma 3:41

2M ago3:41

3:41

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer 3:23

2M ago3:23

3:23

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma 3:11

2M ago3:11

3:11

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

1
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer 3:44

2M ago3:44

3:44

Did you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.

Podcasty warte posłuchania

NEJM Podcasty

Podcasty warte posłuchania

Skrócona instrukcja obsługi